(Q34488558)

2 August 2017

title

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Jennifer J Gassman

1

1 reference

2 August 2017

Tom Greene

2

1 reference

2 August 2017

Jackson T Wright

3

1 reference

2 August 2017

Lawrence Agodoa

4

1 reference

2 August 2017

George Bakris

5

1 reference

2 August 2017

Gerald J Beck

6

1 reference

2 August 2017

Janice Douglas

7

1 reference

2 August 2017

Ken Jamerson

8

1 reference

2 August 2017

Julia Lewis

9

1 reference

2 August 2017

Michael Kutner

10

1 reference

2 August 2017

Otelio S Randall

11

1 reference

2 August 2017

Shin-Ru Wang

12

1 reference

2 August 2017

language of work or name

1 reference

1 July 2003

1 reference

Journal of the American Society of Nephrology

2 August 2017

published in

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

7 Suppl 2

1 reference

2 August 2017

page(s)

S154-65

1 reference

Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Antihypertensive treatment: does the J-curve exist?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Pathophysiology and treatment implications of hypertension in the African-American population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Essential hypertension: a renal disease? A review and update of the evidence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

An approximate generalized linear model with random effects for informative missing data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Random-effects models for longitudinal data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Beta-blockers and the kidney

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Systemic hypertension and the kidney in black patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

A Multiple Testing Procedure for Clinical Trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Target organ damage in black hypertensives

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

A model for a proportional treatment effect on disease progression.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN)

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417393

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

9 December 2018

1 reference

12 December 2020

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

12 December 2020

Blood pressure and end-stage renal disease in men

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Effects of treatment in hypertension. Results of a controlled study

1 reference

12 December 2020

The value of aggressive therapy in the hypertensive patient with azotemia

1 reference

12 December 2020

Role of renal hemodynamics and arterial pressure in aldosterone "escape"

1 reference

12 December 2020

Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients

1 reference

12 December 2020

Excessive sodium retention as a characteristic of salt-sensitive hypertension

1 reference

12 December 2020

Disparate cardiovascular findings in men and women with essential hypertension

1 reference

12 December 2020

Renal insufficiency in treated essential hypertension

1 reference

12 December 2020

Progression of renal insufficiency: role of blood pressure

1 reference

12 December 2020

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy

1 reference

12 December 2020

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

1 reference

12 December 2020

10.1097/01.ASN.0000070080.21680.CB

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference